Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:1-4
Published online before print December 4, 2006, doi: 10.1161/01.HYP.0000252753.63224.3b
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/1/1    most recent
01.HYP.0000252753.63224.3bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heerkens, E. H.J.
Right arrow Articles by Heagerty, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heerkens, E. H.J.
Right arrow Articles by Heagerty, A. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Remodeling
Right arrow Cell biology/structural biology
Right arrow Cell signalling/signal transduction
Right arrow Hypertrophy
Right arrow Other Vascular biology

(Hypertension. 2007;49:1.)
© 2007 American Heart Association, Inc.


Hypertension Highlights

Integrins, Vascular Remodeling, and Hypertension

Egidius H.J. Heerkens; Ashley S. Izzard; Anthony M. Heagerty

From the Division of Cardiovascular and Endocrine Sciences, Faculty of Medical and Human Sciences, University of Manchester, United Kingdom.

Correspondence to Anthony M. Heagerty, Division of Cardiovascular and Endocrine Sciences, Faculty of Medical and Human Sciences, University of Manchester, Core Technology Facility, 46 Grafton St, Manchester, M13 9NT United Kingdom. E-mail tony.heagerty@manchester.ac.uk


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
At the level of the resistance artery, hypertension also brings about a thickening of the vascular wall and inward encroachment on the lumen. This has been reported as being attributable to hypertrophy or hyperplasia of vascular smooth muscle cells (VSMCs), but studies have appeared suggesting that growth is not apparent in arteries at this level of the circulation.1 In addition, detailed structural and mechanical analyses have shown that eutrophic inward remodeling can narrow the vascular lumen without precipitating hypertrophy.2,3 A small amount of hypertrophy may be observed, and in some pathological states, hypertrophy may supervene and is an adverse prognostic sign.4 For the remainder of this section, we consider the reasons why resistance arteries respond to hypertension in this manner.

To understand how hypertension produces the above nonhypertrophic changes in small arteries, one must look at the role of the resistance vasculature. At physiological pressures, these vessels typically exhibit a level of contraction (myogenic tone) independent of neurohormonal influences. This response enables blood vessels to constrict or dilate in response to changes in pressure. This process, known as the myogenic response, is only observed in smaller resistance arteries, which mediate autoregulation of blood flow and stabilize capillary pressure.5

Hypertrophy is observed in vessels that do not possess myogenic tone, whereas, in smaller resistance arteries, an initial increase in pressure will bring about increased myogenic constriction, which, if prolonged, will lead to inward eutrophic remodeling and/or a reduced arterial distensibility.6 This structural difference between large conduit and resistance arteries is apparent . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Zhang, F. Yao, S. T. O'Rourke, S. Y. Qian, and C. Sun
Angiotensin II enhances GABAB receptor-mediated responses and expression in nucleus tractus solitarii of rats
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1837 - H1844.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Khavandi, A. S. Greenstein, K. Sonoyama, S. Withers, A. Price, R. A. Malik, and A. M. Heagerty
Myogenic tone and small artery remodelling: insight into diabetic nephropathy
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 361 - 369.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-H. Liu, M. D'Ambrosio, T.-d. Liao, H. Peng, N.-E. Rhaleb, U. Sharma, S. Andre, H.-J. Gabius, and O. A. Carretero
N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H404 - H412.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. F. Mitchell
Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage
J Appl Physiol, November 1, 2008; 105(5): 1652 - 1660.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Dhaun, J. Goddard, D. E. Kohan, D. M. Pollock, E. L. Schiffrin, and D. J. Webb
Role of Endothelin-1 in Clinical Hypertension: 20 Years On
Hypertension, September 1, 2008; 52(3): 452 - 459.
[Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
K. K. Daugherty
Aliskiren
Am. J. Health Syst. Pharm., July 15, 2008; 65(14): 1323 - 1332.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Yao, C. Sumners, S. T. O'Rourke, and C. Sun
Angiotensin II increases GABAB receptor expression in nucleus tractus solitarii of rats
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2712 - H2720.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. A. Martino, G. Y. Oudit, A. M. Herzenberg, N. Tata, M. M. Koletar, G. M. Kabir, D. D. Belsham, P. H. Backx, M. R. Ralph, and M. J. Sole
Circadian rhythm disorganization produces profound cardiovascular and renal disease in hamsters
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1675 - R1683.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Feihl, L. Liaudet, B. I. Levy, and B. Waeber
Hypertension and microvascular remodelling
Cardiovasc Res, May 1, 2008; 78(2): 274 - 285.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
X. Wu, Y. Yang, P. Gui, Y. Sohma, G. A. Meininger, G. E. Davis, A. P. Braun, and M. J. Davis
Potentiation of large conductance, Ca2+-activated K+ (BK) channels by {alpha}5{beta}1 integrin activation in arteriolar smooth muscle
J. Physiol., March 15, 2008; 586(6): 1699 - 1713.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
U. Sharma, N.-E. Rhaleb, S. Pokharel, P. Harding, S. Rasoul, H. Peng, and O. A. Carretero
Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1226 - H1232.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. F. E. Mann
What's new in hypertension 2007?
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 466 - 470.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Moustafa-Bayoumi, M. A. Alhaj, O. El-Sayed, S. Wisel, M. A. Chotani, Z. A. Abouelnaga, M. D. H. Hassona, K. Rigatto, M. Morris, G. Nuovo, et al.
Vascular Hypertrophy and Hypertension Caused by Transgenic Overexpression of Profilin 1
J. Biol. Chem., December 28, 2007; 282(52): 37632 - 37639.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
K. Sonoyama, A. Greenstein, A. Price, K. Khavandi, and T. Heagerty
Review: Vascular remodeling: implications for small artery function and target organ damage
Therapeutic Advances in Cardiovascular Disease, December 1, 2007; 1(2): 129 - 137.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Korantzopoulos, M. Elisaf, and H. J. Milionis
Multifactorial intervention in metabolic syndrome targeting at prevention of chronic kidney disease ready for prime time?
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2768 - 2774.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Kotlo, S. Shukla, U. Tawar, R. A. Skidgel, and R. S. Danziger
Aminopeptidase N reduces basolateral Na+-K+-ATPase in proximal tubule cells
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1047 - F1053.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Wilson
{alpha}7{beta}1 Integrin: Putting the Brakes on Smooth Muscle Cell Proliferation
Circ. Res., September 28, 2007; 101(7): 651 - 653.
[Full Text] [PDF]


Home page
Diabetes CareHome page
G. Colussi, C. Catena, R. Lapenna, E. Nadalini, A. Chiuch, and L. A. Sechi
Insulin Resistance and Hyperinsulinemia Are Related to Plasma Aldosterone Levels in Hypertensive Patients
Diabetes Care, September 1, 2007; 30(9): 2349 - 2354.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. G. Dechering, A. Adiyaman, M. van der Steen, and T. Thien
Interstudy Variability in the Ambulatory Arterial Stiffness Index
Hypertension, September 1, 2007; 50(3): e65 - e65.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. P. Porter, S. H. King, and A. D. Honeycutt
Prenatal high-salt diet in the Sprague-Dawley rat programs blood pressure and heart rate hyperresponsiveness to stress in adult female offspring
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R334 - R342.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. P. Bagby
Developmental Hypertension, Nephrogenesis, and Mother's Milk: Programming the Neonate
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1626 - 1629.
[Full Text] [PDF]


Home page
HypertensionHome page
M. C. Laterza, L. D.N.J. de Matos, I. C. Trombetta, A. M.W. Braga, F. Roveda, M. J.N.N. Alves, E. M. Krieger, C. E. Negrao, and M. U.P.B. Rondon
Exercise Training Restores Baroreflex Sensitivity in Never-Treated Hypertensive Patients
Hypertension, June 1, 2007; 49(6): 1298 - 1306.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Laurent and P. Boutouyrie
Recent Advances in Arterial Stiffness and Wave Reflection in Human Hypertension
Hypertension, June 1, 2007; 49(6): 1202 - 1206.
[Full Text] [PDF]